Literature DB >> 32856152

Efficacy of endoscopic submucosal tunnel dissection versus endoscopic submucosal dissection for superficial esophageal neoplastic lesions: a systematic review and meta-analysis.

Ting Zhang1, Hao Zhang2, Furui Zhong2, Xuan Wang3.   

Abstract

BACKGROUND: To evaluate the effectiveness of endoscopic submucosal tunnel dissection (ESTD) and endoscopic submucosal dissection (ESD) in superficial esophageal neoplastic lesions (SENL).
METHODS: A comprehensive search for studies investigating the efficacy of ESTD and ESD for SENL was conducted to search for relevant studies through PubMed, Web of Science, Cochrane Library, SinoMed, CNKI, and Wanfang. Weighted pooled rates were calculated for en bloc resection rate, R0 resection rate, operation time, dissection area, dissection speed, and adverse events. The 95% confidence intervals (95%CI) for effect size were used to calculate the pooled value using the fixed- or random-effects model.
RESULTS: A total of seventeen studies with 1161 patients were identified and included in the meta-analysis. The pooled analysis showed that ESTD had significantly higher en bloc resection (OR 3.98; 95% CI 1.74 to 9.12; p = 0.001) and R0 resection rates (OR 2.29; 95% CI 1.54 to 3.46; p < 0.001) than ESD. The operation time in the ESTD group was shorter than that in the ESD group (SMD = - 0.57; 95% CI - 0.95 to - 0.19; p = 0.003). The dissection area of the ESTD group was larger than that in the ESD group (SMD = 0.49; 95% CI 0.16 to 0.83; p = 0.004), and the dissection speed is faster than that in the ESD group (SMD = 1.52; 95%CI 1.09 to 0.83; p < 0.001). There were no significant differences in esophageal stenosis (p = 0.94) between the two techniques. However, ESTD was superior to ESD in other adverse events (p < 0.05).
CONCLUSION: ESTD has a significant advantage over ESD in the treatment of SENL. ESTD has significantly higher en bloc and R0 resection rates and reduced adverse events.

Entities:  

Keywords:  Endoscopic submucosal dissection; Endoscopic submucosal tunnel dissection; Meta-analysis; Superficial esophageal neoplastic

Mesh:

Year:  2020        PMID: 32856152     DOI: 10.1007/s00464-020-07925-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  5 in total

1.  Endoscopic submucosal tunnel dissection for large esophageal neoplastic lesions.

Authors:  E Linghu; X Feng; X Wang; J Meng; H Du; H Wang
Journal:  Endoscopy       Date:  2012-12-19       Impact factor: 10.093

2.  [The Efficiency and Complications of ESD and ESTD in the Treatment of Large Esophageal Mucosal Lesions].

Authors:  Jin Wang; Jin-yu Qin; Tian-jiao Guo; Tao Gan; Yi-ping Wang; Jun-chao Wu
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2015-11

Review 3.  [Endoscopic minimally invasive treatment--from inside the lumen to outside the lumen, from the superficial layer to the deep layer].

Authors:  M Y Cai; Y Zhu; P H Zhou
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2019-07-25

4.  [Comparison of endoscopic submucosal tunnel dissection with endoscopic submucosal dissection for large esophageal superficial neoplasms].

Authors:  Yaqi Zhai; Enqiang Linghu; Huikai Li; Zhichu Qin; Xiuxue Feng; Xiangdong Wang; Hong Du; Jiangyun Meng; Hongbin Wang; Jing Zhu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2014-01

5.  Comparison between tunneling and standard endoscopic submucosal dissection for treatment of large esophageal superficial neoplasm.

Authors:  J Gong; B Y Zhou; C B Liang; H J Zhou; H Y Wang; Y Y Tan; D L Liu
Journal:  Acta Gastroenterol Belg       Date:  2019 Oct-Dec       Impact factor: 1.316

  5 in total
  2 in total

Review 1.  Advances in traction methods for endoscopic submucosal dissection: What is the best traction method and traction direction?

Authors:  Mitsuru Nagata
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

2.  Risk Factors for Fever After Esophageal Endoscopic Submucosal Dissection and Its Derived Technique.

Authors:  Foqiang Liao; Zhenhua Zhu; Yongkang Lai; Xiaolin Pan; Shunhua Long; Xiaojiang Zhou; Guohua Li; Yin Zhu; Youxiang Chen; Xu Shu
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.